WINT – windtree therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

WINT

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

12/16

08:00 am

wint

Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference

Medium Report

Windtree Announces Istaroxime Presentation By Cardiogenic Shock Thought Leader At Cardiovascular Clinical Trials Conference

Report

12/9

08:15 am

wint

Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia [Yahoo! Finance]

Low Report

Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia [Yahoo! Finance]

Report

12/9

08:00 am

wint

Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia

Low Report

Windtree Announces New Istaroxime Patent Filing for Preventing or Reducing the Risk of Acute Myocardial Arrhythmia

Report

12/4

08:12 am

wint

Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction [Yahoo! Finance]

High Report

Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction [Yahoo! Finance]

Report

12/4

08:09 am

wint

Windtree Therapeutics, Inc. (NASDAQ: WINT) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.

High Report

Windtree Therapeutics, Inc. (NASDAQ: WINT) had its "neutral" rating re-affirmed by analysts at HC Wainwright. They now have a $7.00 price target on the stock.

Report

12/4

08:00 am

wint

Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction

High Report

Windtree Announces Partnership with New Growth Advisors to Leverage Positive Phase 2 Istaroxime Study in Cardiogenic Shock for a Potential Strategic Transaction

Report

11/27

04:10 pm

wint

Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates [Yahoo! Finance]

Medium Report

Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates [Yahoo! Finance]

Report

11/27

04:05 pm

wint

Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates

High Report

Windtree Therapeutics Reports Third Quarter 2024 Financial Results and Provides Key Business Updates

Report

Date

Time

Symbol

Company Name

Action

%Chg

Date

Time

Action

From

Firm

Impact

%Chg

12/4

08:09 am

Reiterates

Neutral

HC Wainwright

High

Report

-30.7%

Report

Date

Time

Symbol

Headline

Impact

12/5

07:12 am

wint

Form 8-K WINDTREE THERAPEUTICS For: Dec 02

Medium Report

Form 8-K WINDTREE THERAPEUTICS For: Dec 02

Report

12/4

08:03 am

wint

Form 8-K WINDTREE THERAPEUTICS For: Dec 04

High Report

Form 8-K WINDTREE THERAPEUTICS For: Dec 04

Report

11/27

04:44 pm

wint

Form 8-K WINDTREE THERAPEUTICS For: Nov 21

Medium Report

Form 8-K WINDTREE THERAPEUTICS For: Nov 21

Report

11/26

04:55 pm

wint

Form 10-Q WINDTREE THERAPEUTICS For: Sep 30

Medium Report

Form 10-Q WINDTREE THERAPEUTICS For: Sep 30

Report

11/15

04:32 pm

wint

Form 8-K/A WINDTREE THERAPEUTICS For: Sep 25

Medium Report

Form 8-K/A WINDTREE THERAPEUTICS For: Sep 25

Report

11/15

04:31 pm

wint

Form NT 10-Q WINDTREE THERAPEUTICS For: Sep 30

Medium Report

Form NT 10-Q WINDTREE THERAPEUTICS For: Sep 30

Report

11/14

07:16 pm

wint

Form SC 13G/A WINDTREE THERAPEUTICS Filed by: Lind Global Fund II LP

Medium Report

Form SC 13G/A WINDTREE THERAPEUTICS Filed by: Lind Global Fund II LP

Report

11/14

03:41 pm

wint

Form SC 13G WINDTREE THERAPEUTICS Filed by: ARMISTICE CAPITAL, LLC

Medium Report

Form SC 13G WINDTREE THERAPEUTICS Filed by: ARMISTICE CAPITAL, LLC

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.